First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label,... by Paz-Ares, Luis, Prof, Ciuleanu, Tudor-Eliade, MD, Cobo, Manuel, MD, Schenker, Michael, MD, Zurawski, Bogdan, MD, Menezes, Juliana, MD, Richardet, Eduardo, MD, Bennouna, Jaafar, MD, Felip, Enriqueta, Prof, Juan-Vidal, Oscar, Prof, Alexandru, Aurelia, MD, Sakai, Hiroshi, MD, Lingua, Alejo, MD, Salman, Pamela, Prof, Souquet, Pierre-Jean, MD, De Marchi, Pedro, MD, Martin, Claudio, MD, Pérol, Maurice, MD, Scherpereel, Arnaud, Prof, Lu, Shun, Prof, John, Thomas, MD, Carbone, David P, Prof, Meadows-Shropshire, Stephanie, PhD, Agrawal, Shruti, PhD, Oukessou, Abderrahim, MD, Yan, Jinchun, MD, Reck, Martin, Prof

Get full text

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial by Nakagawa, Kazuhiko, Prof, Garon, Edward B, MD, Seto, Takashi, MD, Nishio, Makoto, MD, Ponce Aix, Santiago, MD, Paz-Ares, Luis, Prof, Chiu, Chao-Hua, MD, Park, Keunchil, Prof, Novello, Silvia, Prof, Nadal, Ernest, MD, Imamura, Fumio, MD, Yoh, Kiyotaka, MD, Shih, Jin-Yuan, MD, Au, Kwok Hung, MD, Moro-Sibilot, Denis, Prof, Enatsu, Sotaro, MD, Zimmermann, Annamaria, MS, Frimodt-Moller, Bente, MSc, Visseren-Grul, Carla, MD, Reck, Martin, Prof

Get full text

Management of non-small-cell lung cancer: recent developments by Reck, Martin, PD Dr, Heigener, David F, MD, Mok, Tony, Prof, Soria, Jean-Charles, Prof, Rabe, Klaus F, Prof

Get full text

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL... by Garon, Edward B, Dr, Ciuleanu, Tudor-Eliade, Prof, Arrieta, Oscar, MD, Prabhash, Kumar, Prof, Syrigos, Konstantinos N, Prof, Goksel, Tuncay, Prof, Park, Keunchil, Prof, Gorbunova, Vera, MD, Kowalyszyn, Ruben Dario, MD, Pikiel, Joanna, MD, Czyzewicz, Grzegorz, MD, Orlov, Sergey V, Prof, Lewanski, Conrad R, MD, Thomas, Michael, Prof, Bidoli, Paolo, MD, Dakhil, Shaker, MD, Gans, Steven, MD, Kim, Joo-Hang, Prof, Grigorescu, Alexandru, Prof, Karaseva, Nina, MD, Reck, Martin, MD, Cappuzzo, Federico, MD, Alexandris, Ekaterine, MS, Sashegyi, Andreas, PhD, Yurasov, Sergey, MD, Pérol, Maurice, MD

Get full text

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled... by Reck, Martin, Dr, Kaiser, Rolf, MD, Mellemgaard, Anders, MD, Douillard, Jean-Yves, Prof, Orlov, Sergey, Prof, Krzakowski, Maciej, Prof, von Pawel, Joachim, MD, Gottfried, Maya, MD, Bondarenko, Igor, Prof, Liao, Meilin, Prof, Gann, Claudia-Nanette, MD, Barrueco, José, PhD, Gaschler-Markefski, Birgit, PhD, Novello, Silvia, Prof

Get full text

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an o... by Thatcher, Nick, Prof, Hirsch, Fred R, Prof, Luft, Alexander V, MD, Szczesna, Aleksandra, MD, Ciuleanu, Tudor E, Prof, Dediu, Mircea, MD, Ramlau, Rodryg, Prof, Galiulin, Rinat K, MD, Bálint, Beatrix, MD, Losonczy, György, Prof, Kazarnowicz, Andrzej, MD, Park, Keunchil, MD, Schumann, Christian, Prof, Reck, Martin, MD, Depenbrock, Henrik, MD, Nanda, Shivani, MS, Kruljac-Letunic, Anamarija, PhD, Kurek, Raffael, MD, Paz-Ares, Luis, MD, Socinski, Mark A, Prof

Get full text

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial by Kim, Edward S, MD, Hirsh, Vera, MD, Mok, Tony, Prof, Socinski, Mark A, Prof, Gervais, Radj, MD, Wu, Yi-Long, Prof, Li, Long-Yun, Prof, Watkins, Claire L, MSc, Sellers, Mark V, MSc, Lowe, Elizabeth S, MD, Sun, Yan, MD, Liao, Mei-Lin, Prof, Østerlind, Kell, MD, Reck, Martin, MD, Armour, Alison A, FRCR, Shepherd, Frances A, Prof, Lippman, Scott M, Prof, Douillard, Jean-Yves, Prof

Get full text

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squam... by Paz-Ares, Luis, Dr, de Marinis, Filippo, MD, Dediu, Mircea, MD, Thomas, Michael, Prof, Pujol, Jean-Louis, Prof, Bidoli, Paolo, MD, Molinier, Olivier, MD, Sahoo, Tarini Prasad, MD, Laack, Eckart, Prof, Reck, Martin, MD, Corral, Jesús, MD, Melemed, Symantha, PhD, John, William, MD, Chouaki, Nadia, MD, Zimmermann, Annamaria H, MS, Visseren-Grul, Carla, MD, Gridelli, Cesare, MD

Get full text

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled p... by Paz-Ares, Luis, Dr, Mezger, Jörg, Prof, Ciuleanu, Tudor E, Prof, Fischer, Jürgen R, MD, von Pawel, Joachim, MD, Provencio, Mariano, Prof, Kazarnowicz, Andrzej, MD, Losonczy, György, Prof, de Castro, Gilberto, MD, Szczesna, Aleksandra, MD, Crino, Lucio, MD, Reck, Martin, MD, Ramlau, Rodryg, Prof, Ulsperger, Ernst, MD, Schumann, Christian, MD, Miziara, Jose Elias A, MD, Lessa, Álvaro E, MD, Dediu, Mircea, MD, Bálint, Beatrix, PhD, Depenbrock, Henrik, MD, Soldatenkova, Victoria, MSc, Kurek, Raffael, MD, Hirsch, Fred R, Prof, Thatcher, Nick, FRCP, Socinski, Mark A, Prof

Get full text

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer... by Garassino, Marina C, MD, Gadgeel, Shirish, MBBS, Esteban, Emilio, MD, Felip, Enriqueta, PhD, Speranza, Giovanna, MD, Domine, Manuel, PhD, Hochmair, Maximilian J, PhD, Powell, Steven, MD, Cheng, Susanna Yee-Shan, MD, Bischoff, Helge G, MD, Peled, Nir, Prof, Reck, Martin, MD, Hui, Rina, PhD, Garon, Edward B, MD, Boyer, Michael, MD, Wei, Ziwen, PhD, Burke, Thomas, PhD, Pietanza, M Catherine, MD, Rodríguez-Abreu, Delvys, MD

Get full text

Catheter-tip Granulomas Associated with Intrathecal Drug Delivery--A Two-Center Experience Identifying 13 Cases by Kratzsch, Tobias, Stienen, Martin N, Reck, Tim, Hildebrandt, Gerhard, Hoederath, Petra

Get full text